Development of a Treatment Regimen for Human Cytomegalovirus (CMV) Infection in Bone Marrow Transplantation Recipients by Adoptive Transfer of Donor‐Derived CMV‐Specific T Cell Clones Expanded In Vitroa
- 17 December 1991
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 636 (1) , 184-195
- https://doi.org/10.1111/j.1749-6632.1991.tb33450.x
Abstract
Click on the article title to read more.Keywords
This publication has 20 references indexed in Scilit:
- The use of anti-CD3 and anti-CD28 monoclonal antibodies to clone and expand human antigen-specific T cellsJournal of Immunological Methods, 1990
- Human cytomegalovirus-specific cytotoxic T cells. Relative frequency of stage-specific CTL recognizing the 72-kD immediate early protein and glycoprotein B expressed by recombinant vaccinia viruses.The Journal of Experimental Medicine, 1988
- Cells Process Exogenous Proteins for Recognition by Cytotoxic T LymphocytesScience, 1988
- Acquisition of Donor Strains of Cytomegalovirus by Renal-Transplant RecipientsNew England Journal of Medicine, 1986
- Risk Factors for Cytomegalovirus Infection after Human Marrow TransplantationThe Journal of Infectious Diseases, 1986
- Significance of herpesvirus immediate early gene expression in cellular immunity to cytomegalovirus infectionNature, 1984
- Importance of cytotoxic lymphocytes during cytomegalovirus infection in renal transplant recipientsThe American Journal of Medicine, 1984
- Nonbacterial Pneumonia After Allogeneic Marrow Transplantation: A Review of Ten Years' ExperienceClinical Infectious Diseases, 1982
- Cytotoxic T Cells in Cytomegalovirus InfectionNew England Journal of Medicine, 1982
- Cytomegalovirus Disease in Renal Allograft RecipientsMedicine, 1980